The contraceptive market is expected to grow at a CAGR of 6.48%, reaching a market size of US$47.386 billion in 2030 from US$34.613 billion in 2025.
Contraception is the application that prevents a woman from pregnancy through medications or devices. Other commonly known as fertility control and birth control. The market is expected to continue growing as the incidence of STDs rises. More women are seeking contraceptive medicines and devices, particularly among young women who are beginning to use contraception as they attain higher levels of education.
Furthermore, the health risks posed by teenage pregnancy, increased awareness regarding modern contraceptive methods, and a growing preference for oral contraceptives as the principal method to avoid unintended pregnancy are expected to drive market growth over the next few years.
Contraceptive Market Drivers
The growing need for population control is contributing to the contraceptive market growth
Government measures to control population growth in various countries have increased awareness of family planning and contraception among women in both rural and urban areas. Additionally, rising incidences of unintended pregnancies have led to increased utilization of oral contraceptives, especially in developed markets. Particularly in Asian countries, the population is expanding at an incredible rate, impacting the microeconomic balance. The public and private sectors are working together to control this growing population, which should benefit sex education and the use of contraceptives in the years to come. This is expected to drive the market revenue for oral contraceptives during the forecast period.
Contraceptive Market Geographical Outlook:
North America is witnessing exponential growth during the forecast period.
The market growth in North America includes the inclination of young people toward sexual activities and the high awareness of reproductive health and contraception among them regarding the matters. Teenagers in the regions need contraceptives more due to the introduction and spread of cheap generic products and devices. The expansion of publicly funded family planning services and the rise in social organization efforts in the US to increase access to contraception. Most importantly, the two government-aided initiatives where insurance covers contraceptive methods- the Affordable Care Act and Title X- have made these products accessible and affordable.
Reasons for buying this report:
Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
Historical data & forecasts from 2022 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
The contraceptive market is segmented and analyzed as follows:
By Product
Drugs
Contraceptive Pills
Injectable Contraceptives
Topical Contraceptives
Devices
Condoms
Intrauterine Devices (IUDs)
Diaphragms
Rings
Others
By Distribution Channel
Online
Offline
By Age Group
15–24 years
25–34 years
35–44 years
Above 44 years
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Others
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook